Roche is barred from selling drug
From Times Wire Services
Roche Holding was barred by an appeals court from selling the anemia drug Mircera in the U.S. after a judge found that the Swiss company infringed patents held by Thousand Oaks-based Amgen Inc.
The U.S. Court of Appeals for the Federal Circuit upheld a February order by U.S. District Judge William Young in Boston without comment. Young ruled last week that U.S. sales of Mircera should be blocked until the patents expire.